Skip to main content
. 2023 Oct 29;15(21):4593. doi: 10.3390/nu15214593

Table 1.

Characteristics of participants, by EVOO oil categories, of the MICOL/PANEL Study. Castellana Grotte. (BA), Italy (2005–2022).

N *** (2754) EVOO Oil Categories (g/Die)
<20 21–30 31–40 >40 p–Value
645 (23.42) 635 (23.06) 595 (21.60) 879 (31.92)
Gender **
Female 305 (25.6) 282 (23.6) 249 (20.9) 357 (29.9) 0.055
Male 340 (21.8) 353 (22.6) 346 (22.2) 522 (33.4)
Age enrolment (yrs) 46.38 (13.00) 52.15 (13.99) 56.9 (14.77) 61.77 (13.54) <0.001
Age categories (yrs)
<40 256 (42.6) 153 (25.5) 103 (17.1) 89 (14.8) <0.001
40–49 209 (37.0) 167 (29.6) 109 (19.3) 80 (14.2)
50–59 84 (15.6) 130 (24.1) 145 (26.9) 181 (33.5)
60–69 42 (8.3) 103 (20.4) 112 (22.2) 248 (49.1)
70–79 37 (8.7) 65 (15.3) 87 (20.5) 235 (55.4)
≥80 17 (14.3) 17 (14.3) 39 (32.8) 46 (38.7)
DBP (mmHg) * 116.68 (18.67) 121.41 (18.56) 125.20 (19.55) 129.27 (19.86) <0.001
SBP (mmHg) * 73.41 (10.23) 74.92 (10.77) 75.40 (9.89) 75.28 (9.69) 0.001
Weight (kg) * 74.58 (15.40) 74.55 (14.82) 75.53 (15.20) 75.75 (15.55) 0.31
BMI (kg/m2) * 27.71 (4.84) 28.34 (4.96) 29.00 (5.26) 29.55 (5.42) <0.001
Kcal days * 2040.92 (712.00) 2161.72 (732.58) 2196.68 (692.40) 2348.09 (687.87) <0.001
TGL (mmol/L) * 1.39 (1.05) 1.49 (1.20) 1.48 (1.03) 1.47 (0.91) 0.23
TC (mmol/L) * 5.17 (0.95) 5.15 (1.05) 5.19 (1.00) 5.14 (1.00) 0.78
HDL (mmol/L) * 1.33 (0.38) 1.32 (0.38) 1.30 (0.34) 1.33 (0.36) 0.36
LDL (mmol/L) * 3.22 (0.80) 3.13 (0.93) 3.21 (0.86) 3.13 (0.85) 0.064
Glucose (mmol/L) * 5.90 (1.40) 6.07 (1.48) 6.08 (1.58) 6.16 (1.51) 0.008
AST (μkat/L) * 0.20 (0.10) 0.21 (0.13) 0.22 (0.15) 0.23 (0.22) 0.001
ALT (μkat/L) * 0.29 (0.18) 0.30 (0.26) 0.30 (0.25) 0.30 (0.30) 0.95
Smoker ***
Never/Former 498 (21.9) 516 (22.7) 502 (22.1) 756 (33.3) <0.001
Current 147 (30.5) 119 (24.7) 93 (19.3) 123 (25.5)
Age at Death (yrs) ** 59.45 (53.66–68.98) 65.61 (56.95–77.96) 72.37 (60.34–81.60) 78.51 (70.02–85.05) <0.001
Observation time ** (yrs) 16.91 (16.13–17.07) 16.93 (16.12–17.26) 16.94 (16.03–17.43) 16.97 (13.55–17.45) 0.033
Status ***
Alive and/or Censored 562 (27.0) 516 (24.8) 436 (21.0) 565 (27.2) <0.001
Dead 83 (12.3) 119 (17.6) 159 (23.6) 314 (46.5)
Cause of death
Colon Cancer 2 (11.8) 2 (11.8) 5 (29.4) 8 (47.1) 0.68
Liver Cancer 2 (11.1) 4 (22.2) 6 (33.3) 6 (33.3)
OC 22 (16.3) 29 (21.5) 34 (25.2) 50 (37.0)
CVD 20 (10.3) 29 (14.9) 43 (22.2) 102 (52.6)
DSD 4 (9.8) 9 (22.0) 8 (19.5) 20 (48.8)
OCD 33 (12.2) 46 (17.0) 63 (23.3) 128 (47.4)
NAFLD
No 402 (24.9) 371 (23.0) 335 (20.8) 505 (31.3) 0.67
Yes 188 (24.2) 182 (23.4) 177 (22.8) 231 (29.7)
rMED 7.00 (6.00–9.00) 8.00 (6.00–9.00) 8.00 (7.00–9.00) 8.00 (7.00–10.00) <0.001

AST: Aspartate Transaminase ALT: Alanine Amino transferase; BMI: Body Mass Index; TGL: Triglycerides; TC: Total Cholesterol; DBP: Diastolic Blood Pressure; SBP: Systolic Blood Pressure; HDL: High-Density Lipoprotein Cholesterol; LDL: Low-Density Lipoprotein Cholesterol; OC: Other Cancers; CVD: Cardiovascular Disease; DSD: Digestive System Disease; OCD: Other Causes Death. NAFLD: non-alcoholic fatty liver disease. rMED: relative Mediterranean Scoring System. Cells reporting subject characteristics contain * Mean ± (SD). ** Median (IQR). *** Number. (Percentage) Percentage calculated per row.